• Equity PC Ratio   0.57
  • |
  • Index PC Ratio   1.14
  • |
  • Total PC Ratio   0.97
  • |
  • VIX PC Ratio   0.54
  • VIX 14.02
  • VXN 16.95
  • VXO 14.44
  • ISEE 85.00

TruCharts Trading Strategies and Stock Buy/Sell Reports
(Show Details)


Chart Settings
No saved settings found!

Chart Type:
From: / / To: / /
Show detail in :
 Chart Skins:      
Price Overlays:





Indicator Windows:





Company Profile

Trinity Biotech plc acquires, develops, manufactures, distributes, and sells diagnostic test kits and instrumentation worldwide. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, sexually transmitted diseases, and autoimmune disorders. It also sells raw materials to the life sciences industry. In addition, the company offers point of care diagnostic tests, which are carried out in the presence of the patient, principally to diagnose the presence of HIV antibodies in the patient. Its customers include hospitals, clinical laboratories, commercial reference laboratories, and research institutions. Trinity Biotech plc sells its products directly, as well as through distributors and strategic partners. The company was founded in 1992 and is headquartered in Bray, Ireland.

NO
     
TRIB (Trinity Biotech PLC)
Last Trade 1.0953 Date 1/29/2020
Change % -0.43 % Price Change -0.01
Open 1.08 52 Week High 3.36
High 1.1 52 Week Low 0.63
Low 1.05 Type stock
Volume 3098 Average Volume 90774
Prev Close 1.1 Stock Exchange NASDAQ
Bid 1.05 Ask 1.13
Bid Size 203 Ask Size 4
1st Yr Estimated EPS Growth 2nd Yr Estimated EPS Growth
2 Years Forward Earning Yield 2 Years Forward PE Ratio
2 Years EV/Forward EBIT 2 Years EV/Forward EBITDA
Book Value per Share 1.8626 Book Value Yield 1.6933
Buy Back Yield CAPE Ratio 1.5004
Cash Return -0.0021 Cash Flow per Share 0.4337
Cash Flow Yield 0.3943 Dividend Rate
Dividend Yield 5 Year Dividend Yield
Earning Yield -1.2839 EV/EBIT
EV/EBITDA EV / Free Cash Flow
EV / Forward EBIT EV / Forward EBITDA
EV / Forward Revenue EV / Pre Tax Income
EV / Revenue 0.8518 EV / Total Asset 0.4604
Expected Dividend Growth Rate Free Cash Flow per Share -0.1623
Free Caash Flow Ratio Free Cash Flow Yield -0.1476
Forward Calculation Style Forward Dividend Yield
Forward Earning Yield Forward PE Ratio
Forward Return on Asset Forward Return on Equity
Normalized PE Ratio Payout Ratio 0.0
PB Ratio 0.590562 PB Ratio 10 Year Growth -0.05294
PB Ratio 3 Year Growth 1.050849 Cash Ratio 3 Year Average 162.8598
Price to Cash Flow Ratio 2.536371 PEG Payback
PEG Ratio PE Ratio
PE Ratio 10 Year Average 26.090985 PE Ratio 10 Year Growth
PE Ratio 10 Year High 70.786123 PE Ratio 10 Year Low 1.738938
PE Ratio 1 Year Avg 30.708238 PE Ratio 1 Year High 33.239858
PE Ratio 1 Year Low 25.985556 PE Ratio 3 Year Avg 43.851261
PE Ratio 5 Year Avg 35.649858 PE Ratio 5 Year High 70.786123
PE Ratio 5 Year Low 17.683524 Free Cash Flow Ratio 10 Year Growth
Free Cash Flow Ratio 3 Year Avg Price Change 1 Month 1.064447
Price to Cash Ratio 0.916372 Price / EBITDA
Price to Sales Ratio 0.297896 Price to Sales Ratio 10 Year Growth -0.073882
Price to Sales Ratio 3 Year Avg 1.062343 Price to Sales Ratio 5 Year Avg 35.649858
Sale per Share 3.6926 Sales Yield 3.3569
Sustainable Growth Rate -0.5522 Tangible Book Value per Share -0.9098
Tangible Book Value per Share 3 year Avg -0.1045 Tangible Book Value per Share 5 year Avg 0.7153
Total Asset per Share 8.2889 Total Yield
Working Capital per Share 2.641 Working Capital per Share 3 Year Avg 3.5955
Working Capital per Share 5 Year Avg 4.5286 Beta 1.698332